Collins Helen Louise 4
4 · IO Biotech, Inc. · Filed Nov 17, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Collins Helen Louise
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-11-15+64,238→ 64,238 totalExercise: $0.98Exp: 2033-11-15→ Common Stock (64,238 underlying)
Footnotes (1)
- [F1]1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control.